Sign In
Buy HRMY
$35.24
-0.620 (-1.73%)
At Close: Jul 31, 2026
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
08:05am, Thursday, 23'rd Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report first quarter 2026 financial results on Thursday, May 7, 2026, before the
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will present encore open-label extension data from the company's investigation of EPX-
Harmony Biosciences Eyes $1B WAKIX Runway, Teases 2026 Pipeline Catalysts at Needham Conference
03:35am, Wednesday, 15'th Apr 2026
Harmony Biosciences (NASDAQ: HRMY) executives outlined 2026 priorities at Needham and Company's Virtual Healthcare Conference, emphasizing continued growth for WAKIX and multiple late-stage pipeline r
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
04:51pm, Tuesday, 14'th Apr 2026
Harmony Biosciences Holdings, Inc. (HRMY) Presents at 25th Annual Needham Virtual Healthcare Conference Transcript
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
08:05am, Tuesday, 14'th Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Glenn Reicin as Chief Financial Officer, effective immediately, supporting
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
08:05am, Thursday, 02'nd Apr 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Dir
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
08:05am, Tuesday, 31'st Mar 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that Harmony's management team will participate in a fireside chat at the upcoming 25th Annual
Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Receives Average Recommendation of “Hold” from Brokerages
02:40am, Monday, 23'rd Mar 2026
Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY - Get Free Report) has received an average rating of "Hold" from the twelve analysts that are presently covering the firm, MarketBeat Ratings reports.
Harmony Biosciences to Participate in Upcoming Investor Conferences
08:05am, Wednesday, 04'th Mar 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will attend the following upcoming investor conferences. Leeri
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript
03:37pm, Tuesday, 24'th Feb 2026
Harmony Biosciences Holdings, Inc. (HRMY) Q4 2025 Earnings Call Transcript
Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Miss Estimates
10:41am, Tuesday, 24'th Feb 2026
Harmony Biosciences Holdings, Inc. (HRMY) came out with quarterly earnings of $0.38 per share, missing the Zacks Consensus Estimate of $0.84 per share. This compares to earnings of $0.85 per share a y
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
07:30am, Tuesday, 24'th Feb 2026
PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced earnings with reported revenue of $243.8 million for Q4 2025, representing 21% year-over-year
4 Value Stocks to Buy Now Amid AI-Driven Market Volatility
11:45am, Wednesday, 18'th Feb 2026
Value stocks are back in focus as markets remain steady. HRMY, TRIP, AES and CNXC screen cheap on P/CF, offering growth and cash flow strength.
Top 5 Bargain P/B Stocks Investors Should Watch Now
08:15am, Wednesday, 18'th Feb 2026
AES joins four other low P/B stocks that screen for value, growth and liquidity, offering investors undervalued picks to watch in February.
Earnings Preview: Harmony Biosciences Holdings, Inc. (HRMY) Q4 Earnings Expected to Decline
11:01am, Tuesday, 17'th Feb 2026
Harmony Biosciences (HRMY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
